The Phelan-McDermid Podcast: Sharing Research, Progress, and Hope

Phelan-McDermid Syndrome Foundation
  • 5.0 (18)
  • LIFE SCIENCES
  • UPDATED MONTHLY

Stay up-to-date on the cutting edge of science and medicine in the Phelan-McDermid syndrome field! Dr. Lauren Schmitt, the Chief Science Officer of the Phelan-McDermid Syndrome Foundation (PMSF), sits down with top experts driving groundbreaking research, treatment, and care. These engaging conversations deliver the latest breakthroughs in a way that's easy to understand, keeping our PMSF community informed and empowered. You won't want to miss this!

  1. FEB 11

    Dr. Jonathan Santoro - 2025 Shannon O'Boyle Memorial Neuropsychiatric Illness Awardee

    This episode's guest: Dr. Jonathan Santoro, MDPediatric Neurologist & NeuroimmunologistChildren’s Hospital Los Angeles (CHLA)2025 Shannon O’Boyle Memorial Neuropsychiatric Illness Grant Awardee Overview: In this episode, we welcome Dr. Jonathan Santoro, our 2025 Shannon O’Boyle Memorial Neuropsychiatric Illness Grant Awardee, who is pediatric neurologist. Dr. Santoro's work focuses on developmental regression and neuropsychiatric illness, and he shares with Dr. Lauren why his research team is turning its attention to Phelan-McDermid syndrome (PMS). Dr. Santoro’s PMSF-funded project, “Diagnostic Biomarkers in Phelan-McDermid Syndrome-Associated Neuropsychiatric Disease,” uses tests that are already part of standard clinical care (like EEGs, MRIs, blood work, and lumbar punctures), the team will look for biological “signatures”, or biomarkers, to help lead to better diagnosis, earlier detection, and more targeted treatments for individuals with Phelan-McDermid syndrome who experience neuropsychiatric illness. His study is currently enrolling (February 2026) Check out our open studies page for more information: https://pmsf.org/current-open-research/

    16 min

  2. JAN 21

    Every Inch Counts: Updates on the Inchstone Project with Drs. Natasha Ludwig and Jenny Downs

    In this episode, we welcome Dr. Natasha Ludwig (Kennedy Krieger Institute / Johns Hopkins) and Dr. Jenny Downs (Kids Research Institute, Australia) for an exciting update on the Inchstone Project—a collaborative international effort to improve how we measure progress and quality of life for individuals with developmental and epileptic encephalopathies (DEEs), including Phelan-McDermid Syndrome (PMS). We discuss: What the Inchstone Project is and why it matters How families helped shape new research by contributing to the DEE Parent Speak Survey Key findings on quality of life, including the importance of communication, cognitive skills, and touchscreen use What “clinical meaningfulness” really means—and why small changes can have a big impact How this research is informing clinical trial readiness and future interventions What’s next for the Inchstone team, including a follow-up longitudinal study PMS families made up nearly 20% of the study sample! Thank you for helping move science forward. Recorded: July 22, 2025 Aired: January 21, 2026 Updates since being recorded Dr. Ludwig is a confirmed speaker at the 2026 PMSF Family Conference!The paper on quality of life is published! Check it out here: https://link.springer.com/article/10.1007/s11136-025-04153-0

    46 min

  3. 12/03/2025

    Behavior, Cognition, and Beyond: Updates from the PMS Natural History Study with Drs. Audrey Thurm and Latha Soorya

    Drs. Audrey Thurm and Latha Soorya join us to discuss key findings from the NIH-funded Natural History Study in Phelan-McDermid syndrome, including intellectual disability profiles, daily living skill growth, regression, and how caregiver input drives research. Learn how these discoveries are guiding clinical trials, behavioral therapy, and everyday care—and why your family's participation makes all the difference.

    47 min

  4. 09/18/2025

    On the move: Jaguar Gene Therapy Updates

    Amanda Bergen, Director of Communications at the Phelan-McDermid Syndrome Foundation, steps in for Dr. Lauren Schmitt to host a special conversation with Dr. Dan Gallo, Kate Neer, and Gina Newton from Jaguar Gene Therapy. Together, they explore the origins and mission of Jaguar Gene Therapy, provide an overview of the Phelan-McDermid syndrome natural history study (NHS) and why it matters, describe key insights into their gene therapy program, and discuss details about JAG201.  Check out the link to learn more about the NHS: https://pmsf.org/current-open-research/ Check out our previous webinar on the NHS: https://youtu.be/pOzTf3qnNmk?feature=shared Check out the updated FAQs for further information about the ongoing JAG201 gene therapy trial: https://drive.google.com/file/d/1QUfuSUQQ9ozOI2eIloRPbmJJw929l-wO/view?usp=sharing Learn more about Jaguar Gene Therapy: https://jaguargenetherapy.com/

    52 min

  5. 09/02/2025

    Driving Research Breakthroughs: Megan O’Boyle Shares Her Story

    In this episode, Dr. Lauren sits down with Megan O’Boyle, a longtime advocate and parent in the Phelan-McDermid Syndrome Foundation community, to talk about why research funding is so essential. Megan shares her journey with the Foundation, how her family helped shape its commitment to science from the very beginning, and the story behind the Shannon O’Boyle Memorial Grant for Neuropsychiatric Illness. Together, Dr. Lauren and Megan also discuss PMSF’s new fundraising opportunity, Driving Research Breakthroughs, and what it means for the future of research, treatments, and cures. Check out the link to our Driving Research Breakthroughs campaign: https://secure.qgiv.com/for/researchgrants Check out the link to our grant opportunities for researchers: https://pmsf.org/for-researchers/funding-opportunities/

    48 min

  6. 08/06/2025

    The Diagnostic Odyssey: Delays in Diagnosing Phelan-McDermid Syndrome

    In this new episode, Dr. Lauren focuses on the diagnostic odyssey of getting a genetic diagnosis with Drs. Ame Shillington and Sheldon Garrison. Dr. Shillington is a clinical geneticist and assistant professor from Cincinnati Children’s Hospital Medical Center. Dr. Garrison is Research Scientist at Rogers Behavioral Health who is on our Scientific Advisory Committee. Did You Know!? The average delay from initial concern to genetic diagnosis of rare disorders like Phelan-McDermid syndrome is over 9 years!Of individuals who receive a genetic diagnosis due to neurodevelopmental concerns, approximately 90% see improvement in their treatment management and care after receiving the diagnosis!  Tune in to hear more about the research behind the delayed diagnosis of rare genetic disorders like Phelan-McDermid syndrome, and what each is doing to help reduce this delay and increase access to genetic testing!  Check out the papers mentioned in the podcast below to learn more: Dr. Sheldon Garrison: https://pubmed.ncbi.nlm.nih.gov/40750893/  https://pubmed.ncbi.nlm.nih.gov/40252994/ Dr. Ame Shillington: https://pubmed.ncbi.nlm.nih.gov/37642312/  https://pubmed.ncbi.nlm.nih.gov/35769998/

    34 min

  7. 06/19/2025

    New Avenues in Phelan-McDermid Syndrome Research Featuring Drs. Boaz Barak and Haitham Amal

    In this exciting combo episode about new avenues in Phelan-McDermid syndrome research, Dr. Lauren speaks with Dr. Boaz Barak from Tel Aviv University and Dr. Haitham Amal from Hebrew University/Boston Children's Hospital. Dr. Barak describes his work on understanding the process of myelination, where "electrical cables" help brain cells to communicate, and how SHANK3 is involved in this process. He also discusses his lab's work on possible treatments for Phelan-McDermid syndrome. Dr. Barak's work was recently awarded Autism Science Foundation's Profound Autism Pilot Grants! Read more here: https://autismsciencefoundation.org/asf-funded-research/ Dr. Amal explains why nitric oxide (NO) is important for brain functioning and how NO is linked to autism as well as Phelan-McDermid Syndrome. He also describes his ongoing work with the two companies that he co-founded, NeuroNOS and Point6 Bio. NeurNOS's lead investigational therapy, BA-102, for the treatment of Phelan-McDermid Syndrome (PMS) just received Orphan Drug status from the FDA! Learn more here: https://www.neuro-nos.com/oddpms Don't forget to subscribe wherever you get your podcasts to discover groundbreaking research uncovering new paths in understanding and treating Phelan-McDermid Syndrome — hope and progress are on the horizon!

    28 min

  8. 06/12/2025

    Dr. Pilar Trelles and Tess Levy - 2024 Shannon O'Boyle Memorial Neuropsychiatric Illness Awardees

    In this episode, Dr. Lauren speaks with the 2024 Shannon O’Boyle Memorial Neuropsychiatric Illness Grant awardees, Tess Levy of the Seaver Autism Center at Mount Sinai and Dr. Pilar Trelles of Boston Children’s Hospital. In their project titled, "Adapting PIPS for Progress: Development and Validation of an Ecological Momentary Assessment Tool to Enhance Psychiatric Symptoms, Monitoring and Intervention Response in Phelan-McDermid Syndrome", they address the need for better measurement tools of neuropsychiatric symptoms in Phelan-McDermid syndrome as well as the importance of involving caregivers and medical experts in the process of developing measures. Tune in to hear more about the measure and why it's so needed! Interested in participating in their study and filling out the updated measure? Act fast! They are collecting data for a only a few more days! You can participate here: https://redcap.link/014yntw7 Tune in now, and don't forget to subscribe to this podcast so you never miss an episode!

    29 min
See All (34)

Ratings & Reviews

5
out of 5
18 Ratings

About

Stay up-to-date on the cutting edge of science and medicine in the Phelan-McDermid syndrome field! Dr. Lauren Schmitt, the Chief Science Officer of the Phelan-McDermid Syndrome Foundation (PMSF), sits down with top experts driving groundbreaking research, treatment, and care. These engaging conversations deliver the latest breakthroughs in a way that's easy to understand, keeping our PMSF community informed and empowered. You won't want to miss this!

Information

You Might Also Like